Bill > S1784

This bill, known as the Mapping America's Pharmaceutical Supply Act (MAPS Act), aims to improve the United States' understanding and management of pharmaceutical supply chains through several key provisions. The bill requires the Secretary of Health and Human Services to develop and maintain an Essential Medicines List that includes critical drugs important for national security, public health emergencies, and military preparedness, with updates at least every two years. The Secretary must also conduct a comprehensive risk assessment of these essential medicine supply chains, identifying key manufacturing materials, foreign dependencies, domestic manufacturing capabilities, and potential national security risks. Additionally, the bill mandates the creation of a supply chain mapping system using data analytics to visualize the entire production process from raw materials to finished drugs, facilitating information sharing between federal agencies and identifying potential vulnerabilities. The Department of Defense is required to submit biannual reports on drugs purchased that involve materials or manufacturing from China, and the bill includes provisions to protect confidential commercial information while ensuring robust cybersecurity measures. The ultimate goal is to reduce the United States' reliance on foreign suppliers for critical medicines and improve the resilience of pharmaceutical supply chains against potential disruptions.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/1784/all-info